Invention Grant
- Patent Title: Prognosis biomarkers for triple-negative breast cancer
-
Application No.: US16915254Application Date: 2020-06-29
-
Publication No.: US11306363B2Publication Date: 2022-04-19
- Inventor: Kuang-Wen Liao , Hsien-Da Huang , Hsiao-Chin Hong , Cheng-Hsun Chuang
- Applicant: NATIONAL CHIAO TUNG UNIVERSITY
- Applicant Address: TW Hsinchu
- Assignee: NATIONAL CHIAO TUNG UNIVERSITY
- Current Assignee: NATIONAL CHIAO TUNG UNIVERSITY
- Current Assignee Address: TW Hsinchu
- Agency: Rabin & Berdo, P.C.
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886
Abstract:
A microRNA (miRNA) expression signature for predicting triple-negative breast cancer (TNBC) recurrence is provided. The miRNA expression signature consists essentially of hsa-miR-139-5p, hsa-miR-10b-5p, hsa-miR-486-5p, hsa-miR-455-3p, hsa-miR-107, hsa-miR-146b-5p, hsa-miR-324-5p, and hsa-miR-20a-5p.
Public/Granted literature
- US20210404008A1 PROGNOSIS BIOMARKERS FOR TRIPLE-NEGATIVE BREAST CANCER Public/Granted day:2021-12-30
Information query
IPC分类:
